{
  "actions": [
    {
      "acted_at": "2001-12-04", 
      "references": [
        {
          "reference": "CR S12376-12385", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-12-04", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1764-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "107", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-12-04", 
  "number": "1764", 
  "official_title": "A bill  to provide incentives to increase research by commercial, for-profit entities to develop vaccines, microbicides, diagnostic technologies, and other drugs to prevent and treat illnesses associated with a biological or chemical weapons attack.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Robert Stevens, Thomas Morris Jr., Joseph Curseen, Kathy Nguyen, Ottilie Lundgren, and Lisa J. Raines Biological and Chemical Weapons Research Act", 
  "sponsor": {
    "district": null, 
    "name": "Lieberman, Joseph I.", 
    "state": "CT", 
    "thomas_id": "01385", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-12-04", 
  "subjects": [
    "Actions and defenses", 
    "Administrative procedure", 
    "Armed forces and national security", 
    "Biological warfare", 
    "Biological weapons", 
    "Biomedical engineering", 
    "Biotechnology", 
    "Business income tax", 
    "Business losses", 
    "Business records", 
    "Capital formation", 
    "Capital gains tax", 
    "Chemical warfare", 
    "Chemical weapons", 
    "Clinical trials", 
    "Commerce", 
    "Communicable diseases", 
    "Corporation taxes", 
    "Crime and law enforcement", 
    "Damages", 
    "Department of Health and Human Services", 
    "Drug approvals", 
    "Drug industry", 
    "Drug therapy", 
    "EBB Terrorism", 
    "Economics and public finance", 
    "Emergency management", 
    "Emergency medical services", 
    "Executive Office of the President", 
    "Federal aid to medical research", 
    "Finance and financial sector", 
    "Government contractors", 
    "Government liability", 
    "Government operations and politics", 
    "Government procurement", 
    "Government publicity", 
    "Government trust funds", 
    "Health", 
    "Income tax", 
    "Indemnity", 
    "Intellectual property", 
    "International affairs", 
    "Joint ventures", 
    "Laboratories", 
    "Law", 
    "Liability (Law)", 
    "Medical laboratories", 
    "Medical research", 
    "Medical supplies", 
    "Minimum tax", 
    "Orphan drugs", 
    "Partnerships", 
    "Patent licenses", 
    "Patents", 
    "Pharmaceutical research", 
    "Products liability", 
    "Public-private partnerships", 
    "Research and development", 
    "Research and development facilities", 
    "Research and development tax credit", 
    "Research centers", 
    "Research grants", 
    "Science, technology, communications", 
    "Small business", 
    "Stocks", 
    "Subsidiary corporations", 
    "Tax credits", 
    "Tax deductions", 
    "Tax exclusion", 
    "Tax rates", 
    "Tax refunds", 
    "Taxation", 
    "Terrorism", 
    "Torts", 
    "Vaccines", 
    "Victims of terrorism", 
    "Weapons of mass destruction"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-12-04", 
    "text": "Robert Stevens, Thomas Morris Jr., Joseph Curseen, Kathy Nguyen, Ottilie Lundgren, and Lisa J. Raines Biological and Chemical Weapons Research Act - Requires the Director of the Office of Homeland Security to publish and annually revise a list of biological and chemical agents and toxins that may be used as weapons of mass destruction. Sets forth the criteria for inclusion on such list, including the degree of risk presented and the likelihood of countermeasure development.Makes entities engaged in countermeasure research eligible for tax incentives, participation in the Bioterrorism Countermeasures Purchase Fund, and patent extension and liability protections, as specified.Sets forth the tax incentives which include limited partnerships, total exclusion for gain from stock, and special countermeasure research credits.Provides for the establishment of the Bioterrorism Countermeasures Purchase Fund to purchase countermeasures. Provides for such countermeasures' distribution by the Director of the Centers for Disease Control and Prevention.Provides for the election of extended patent protection for eligible countermeasures, as specified.Amends the Public Health Service Act to indemnify and defend persons and entities engaged in the research, production, or use of countermeasures.Authorizes the Director of the National Institutes of Health to award grants and contracts for the construction of certain biosafety research facilities.Authorizes the Director to award partnership challenge grants to promote joint ventures between the public and private sectors for the development of countermeasures and research tools."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Robert Stevens, Thomas Morris Jr., Joseph Curseen, Kathy Nguyen, Ottilie Lundgren, and Lisa J. Raines Biological and Chemical Weapons Research Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill  to provide incentives to increase research by commercial, for-profit entities to develop vaccines, microbicides, diagnostic technologies, and other drugs to prevent and treat illnesses associated with a biological or chemical weapons attack.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:47:17-05:00"
}